Fingerprint
Dive into the research topics of 'Low-dose IL-17 therapy prevents and reverses diabetic nephropathy, metabolic syndrome, and associated organ fibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Low-dose IL-17 therapy prevents and reverses diabetic nephropathy, metabolic syndrome, and associated organ fibrosis
Riyaz Mohamed, Calpurnia Jayakumar, Feng Chen, David Fulton, David Stepp, Ron T. Gansevoort, Ganesan Ramesh
Research output: Contribution to journal › Article › peer-review
87
Scopus
citations